Hematology

The limitations of currently available therapies for immune thrombocytopenia (ITP) mean that long-term responses are difficult to maintain…

Find out more about the current management and patient experience of warm autoimmune haemolytic anaemia (wAIHA)…

We are delighted to announce the release of the latest EMJ Hematology journal! Packed with a diverse array of content, this issue…

Don’t miss this interview with two co-authors of the ‘IMROZ’ study, the first global Phase III study of an anti-CD38 monoclonal antibody…

Welcome to our supplement providing an excellent review of the European Association for Haemophilia and Allied Disorders (EAHAD)…

The AZALEA-TIMI 71 trial is the first study to provide definitive evidence that factor XI inhibition substantially reduces bleeding…

Pyruvate kinase (PK) deficiency is a rare genetic disorder causing non-spherocytic haemolytic anaemia due to impaired adenosine…

The thalassaemias are a heterogenous group of inherited blood disorders with the commonality of impaired haemoglobin synthesis, resulting…